Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018;15(4-5):623-634.
doi: 10.1080/15476286.2017.1330245. Epub 2017 Jun 30.

Human aminoacyl-tRNA synthetases in diseases of the nervous system

Affiliations
Review

Human aminoacyl-tRNA synthetases in diseases of the nervous system

Jana Ognjenović et al. RNA Biol. 2018.

Abstract

Aminoacyl-tRNA synthetases (AaRSs) are ubiquitously expressed enzymes that ensure accurate translation of the genetic information into functional proteins. These enzymes also execute a variety of non-canonical functions that are significant for regulation of diverse cellular processes and that reside outside the realm of protein synthesis. Associations between faults in AaRS-mediated processes and human diseases have been long recognized. Most recent research findings strongly argue that 10 cytosolic and 14 mitochondrial AaRSs are implicated in some form of pathology of the human nervous system. The advent of modern whole-exome sequencing makes it all but certain that similar associations between the remaining 15 ARS genes and neurologic illnesses will be defined in future. It is not surprising that an intense scientific debate about the role of translational machinery, in general, and AaRSs, in particular, in the development and maintenance of the healthy human neural cell types and the brain is sparked. Herein, we summarize the current knowledge about causative links between mutations in human AaRSs and diseases of the nervous system and briefly discuss future directions.

Keywords: Aminoacyl-tRNA synthetase; encephalopathy; mutation; neurodegenerative disease; neuropathy; ponto-cerebellar hypoplasia; tRNA.

PubMed Disclaimer

References

    1. Ibba M, Söll D. Aminoacyl-tRNA synthesis. Annu Rev Biochem 2000; 69:617-50; PMID:10966471; https://doi.org/10.1146/annurev.biochem.69.1.617 - DOI - PubMed
    1. Guo M, Schimmel P, Yang XL. Functional expansion of human tRNA synthetases achieved by structural inventions. FEBS Lett 2010; 584:434-42; PMID:19932696; https://doi.org/10.1016/j.febslet.2009.11.064 - DOI - PMC - PubMed
    1. Guo M, Yang XL, Schimmel P. New functions of aminoacyl-tRNA synthetases beyond translation. Nat Rev Mol Cell Biol 2010; 11; 668-74; PMID:20700144; https://doi.org/10.1038/nrm2956 - DOI - PMC - PubMed
    1. Mirande M. The Aminoacyl-tRNA Synthetase Complex. Subcell Biochem 2017; 83:505-522; PMID:28271488; https://doi.org/10.1007/978-3-3319-46503-6_18 - DOI - PubMed
    1. Woese CR, Olsen GJ, Ibba M, Söll D. Aminoacyl-tRNA synthetases, the genetic code, and the evolutionary process. Microbiol Mol Biol Rev 2000; 64:202-36; PMID:10704480; https://doi.org/10.1128/MMBR.64.1.202-236.2000 - DOI - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts